1. Home
  2. AGAE vs ELUT Comparison

AGAE vs ELUT Comparison

Compare AGAE & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allied Gaming & Entertainment Inc.

AGAE

Allied Gaming & Entertainment Inc.

HOLD

Current Price

$0.43

Market Cap

24.3M

ML Signal

HOLD

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.56

Market Cap

23.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGAE
ELUT
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Medical Specialities
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
23.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AGAE
ELUT
Price
$0.43
$0.56
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
1.2M
447.8K
Earning Date
11-19-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,938,232.00
$21,746,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$0.34
$0.50
52 Week High
$3.79
$4.84

Technical Indicators

Market Signals
Indicator
AGAE
ELUT
Relative Strength Index (RSI) 52.42 37.84
Support Level $0.34 $0.53
Resistance Level $0.38 $0.65
Average True Range (ATR) 0.04 0.06
MACD 0.02 -0.00
Stochastic Oscillator 92.72 26.92

Price Performance

Historical Comparison
AGAE
ELUT

About AGAE Allied Gaming & Entertainment Inc.

Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: